Envestnet Asset Management
NUVB icon

Envestnet Asset Management’s Nuvation Bio NUVB Stock Holding History

Envestnet Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,419
Closed -$92.5K – 4619
2025
Q2 		$92.5K Buy
+47,419
New +$98.8K ﹤0.01% 4346

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Envestnet Asset Management's NUVB Position: Q3 2025 in Review

Envestnet Asset Management sold out of Nuvation Bio (NUVB) in Q3 2025, closing a stake of 47,419 shares — an estimated $92.5K sold.

Envestnet Asset Management first reported a position in NUVB in Q2 2025 and held it in 1 quarter. The position peaked at $92.5K in Q2 2025. 203 funds tracked by Wall St. Rank hold NUVB as of Q3 2025.

  • Envestnet Asset Management reported no remaining Nuvation Bio position as of Q3 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 47,419 Nuvation Bio shares in Q3 2025, an estimated $92.5K.
  • Envestnet Asset Management first reported a position in Nuvation Bio in Q2 2025 and held it in 1 quarter.
  • Envestnet Asset Management's Nuvation Bio position peaked at $92.5K in Q2 2025.
  • 203 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2025.

Based on Envestnet Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.